Literature DB >> 25159464

Defective B-cell memory in patients with Down syndrome.

Ruud H J Verstegen1, Gertjan J Driessen2, Sophinus J W Bartol3, Carel J M van Noesel4, Louis Boon5, Mirjam van der Burg3, Jacques J M van Dongen3, Esther de Vries6, Menno C van Zelm3.   

Abstract

BACKGROUND: Patients with Down syndrome carry immunologic defects, as evidenced by the increased risks for autoimmune diseases, hematologic malignancies, and respiratory tract infections. Moreover, the low numbers of circulating B cells suggest impaired humoral immunity.
OBJECTIVE: We sought to study how immunodeficiency in patients with Down syndrome results from immunologic defects in the B-cell compartment.
METHODS: We studied blood B-cell subset composition, replication history, somatic hypermutation status, and class-switch recombination in 17 children with Down syndrome. Germinal centers and plasma cells were studied in tonsils from 4 additional children with Down syndrome.
RESULTS: Blood transitional B-cell numbers were normal, but naive mature and memory B-cell numbers were reduced despite slightly increased serum B cell-activating factor levels. Germinal centers and plasma cells in tonsils appeared normal, as were serum immunoglobulin levels. CD27(+)IgD(+)IgM(+) "natural effector" B cells showed reduced proliferation and somatic hypermutation levels, whereas these were normal in CD27(+)IgD(-) memory B cells. Furthermore, IgM(+) and IgA(+), but not IgG(+), memory B cells showed impaired molecular signs for antigen selection. The B-cell pattern was highly similar to that of patients with common variable immunodeficiency and a defect in B-cell activation and proliferation.
CONCLUSION: Children with Down syndrome seem capable of normal germinal center and plasma cell formation. Still, blood memory B-cell numbers were reduced and showed impaired molecular maturation of IgA and IgM, which are important for mucosal immunity. The observed molecular defects in circulating IgA and IgM B-cell memory could reflect impaired local responses, which underlie the increased susceptibility to respiratory tract infections of patients with Down syndrome.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B cell; Down syndrome; IgA; IgM; antibody; common variable immunodeficiency; plasma cell; selection; somatic hypermutation

Mesh:

Substances:

Year:  2014        PMID: 25159464     DOI: 10.1016/j.jaci.2014.07.015

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  19 in total

1.  Complications of accelerated corneal collagen cross-linking: review of 2025 eyes.

Authors:  Semih Çakmak; Mehmet Emin Sucu; Yusuf Yildirim; Burcin Kepez Yildiz; Ahmet Kirgiz; Damla Leman Bektaşoğlu; Ahmet Demirok
Journal:  Int Ophthalmol       Date:  2020-07-26       Impact factor: 2.031

2.  Age-related alterations of the CD19 complex and memory B cells in children with Down syndrome.

Authors:  Ayse Nazli Seckin; Hulya Ozdemir; Ayca Ceylan; Hasibe Artac
Journal:  Clin Exp Med       Date:  2017-02-14       Impact factor: 3.984

3.  Adults with Trisomy 21 Have Differential Antibody Responses to Influenza A.

Authors:  Stephanie James; Robert C Haight; Cassandra Hanna; Lindsey Furton
Journal:  Vaccines (Basel)       Date:  2022-07-19

4.  Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunity.

Authors:  Katharina Lambert; Keagan G Moo; Azlann Arnett; Gautam Goel; Alex Hu; Kaitlin J Flynn; Cate Speake; Alice E Wiedeman; Vivian H Gersuk; Peter S Linsley; Carla J Greenbaum; S Alice Long; Rebecca Partridge; Jane H Buckner; Bernard Khor
Journal:  Sci Transl Med       Date:  2022-01-12       Impact factor: 19.319

Review 5.  Beyond amyloid: Immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome.

Authors:  Alessandra C Martini; Thomas J Gross; Elizabeth Head; Mark Mapstone
Journal:  Neuron       Date:  2022-04-25       Impact factor: 18.688

6.  Severe scarlet fever in a child with Down syndrome - a case report.

Authors:  Halyna Pavlyshyn; Ivanna Horishna; Iryna Sarapuk
Journal:  Germs       Date:  2020-09-01

7.  Analysis of the intracellular traffic of IgG in the context of Down syndrome (trisomy 21).

Authors:  R B Cejas; M Tamaño-Blanco; J G Blanco
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

Review 8.  Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.

Authors:  Tomer Illouz; Arya Biragyn; Maria Florencia Iulita; Lisi Flores-Aguilar; Mara Dierssen; Ilario De Toma; Stylianos E Antonarakis; Eugene Yu; Yann Herault; Marie-Claude Potier; Alexandra Botté; Randall Roper; Benjamin Sredni; Jacqueline London; William Mobley; Andre Strydom; Eitan Okun
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

9.  The 11q Terminal Deletion Disorder Jacobsen Syndrome is a Syndromic Primary Immunodeficiency.

Authors:  Virgil A S H Dalm; Gertjan J A Driessen; Barbara H Barendregt; Petrus M van Hagen; Mirjam van der Burg
Journal:  J Clin Immunol       Date:  2015-11-14       Impact factor: 8.317

10.  B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.

Authors:  Wilhelmina M C Timmermans; Jan A M van Laar; Tim B van der Houwen; Lieke S J Kamphuis; Sophinus J W Bartol; King H Lam; Rob J Ouwendijk; Miles P Sparrow; Peter R Gibson; P Martin van Hagen; Menno C van Zelm
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.